Efficacy and safety of slow and rush oral immunotherapy for patients with food allergy

Efficacy and safety of slow and rush oral immunotherapy for patients with food allergy - Slow and rush oral immunotherapy for patients with food allergies

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019699

Enrollment

Registered

2015-11-16

Start date

2015-11-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Food allergy

Interventions

Cow&#39

s milk, hen&#39

s egg, wheat, foods caused by allergy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients that have positive reactions at food challenge 2) The patients that show more than 0.35 UA/ml of specific IgE level and were positive for skin prick test 3) The patients that written informed consent is obtained

Exclusion criteria

Exclusion criteria: 1) severe bronchial asthma 2) severe atopic dermatitis 3) acute severe illenes 4) Decision of ineligibility by a physician

Design outcomes

Primary

Measure	Time frame
1. Evaluation of the symptom provocation threshold change at the time of entry and 12 months after the start of oral immunotherapy and frequencies of allergic symptoms during the 12 months.	—

Secondary

Measure	Time frame
1. Analysis of immunologic parameters in blood samples and measurements of prick test at entry, food challenge and 1 year late the entry. 2. Analysis of adverse effects during this clinical study.	—

Countries

Japan

Contacts

Public ContactMasaya Takahashi

Kansai Medical University Department of Pediatrics

takahasm@hirakata.kmu.ac.jp072-804-0101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026